• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

What happened at a study visit?

How did a research participant get enrolled into the EPAD cohort?

Joining the EPAD Longitudinal Cohort Study (LCS) involved a number of steps.

  1. The EPAD study team contacted participants by phone, e-mail or letter – each centre manages this process in their own way. They gave some information and were able to answer any questions participants may have.
  2. If participants were interested in joining the study, they were be asked to identify a relative or friend who knew them well and was willing to be their study partner. This person was asked to answer some standard questionnaires.
  3. Once participants read the information sheet and had all of their questions answered, they were asked if they wish to sign the consent form. Their study partner also received an information sheet and was asked to sign their own consent form.
  4. On the day that participants signed the consent form, they were asked to stay in the unit to complete its first visit which was called a ‘screening visit’. This allowed our researchers to double check that participants were suitable to enter the EPAD Cohort.
  5. Additional visits were planned for participants after 6 months, 1 year, 2 years, 3 years, and 4 years. We arranged these follow up visits to make sure that participants’ health has not changed and to measure changes in certain tests that may or may not be related to Alzheimer’s disease.

What happened at EPAD cohort study visits?

During each visit, several assessments were necessary.

First screening visit

On arrival at the research site for the first screening visit, participants had the opportunity to ask any questions they might have. Once participants were happy with their involvement in the study, they signed a consent form. They were then be asked to complete a number of forms and took part in interviews with the study doctor, nurse and psychologist. These forms and interviews gathered a range of information about participants and their health.

Annual visits

The annual visit to the research centre could take up to about 5 hours in total. Participants were asked to fast before attending so that fasting blood samples was taken. There was also be a separate visit for a brain scan (MRI). The MRI brain scan takes about 80 minutes. Including the time to get ready for the scan, participants were expected to be at the imaging facility for a total visit time of 2 hours. These assessments were compulsory for EPAD research participation.

Screening feedback

EPAD’s study staff did not conduct a full and thorough physical examination. However, if during any of the testing we noted any health issues, we discussed these with participants and provided help in planning potential next steps if participants consented for us to do so.

 

Share this page
FacebookTwitterLinkedInGoogle+
Latest News
  • New paper on the Open-Access EPAD MRI dataset and processing workflow
    2022-07-13
  • Edinburgh Dementia Prevention Summer School 2022
    2022-06-30
  • EPAD at AAIC22!
    2022-06-30
  • ADDI NeuroToolKit Data Hackathon
    2022-05-17
  • The Neuronet Coordination and Support Action releases updated Decision Tool for engagement with Regulatory and Health Technology Assessment bodies
    2022-05-09
View the EPAD Brochure
thumbnail of EPAD brochure
Speak to the EPAD team
thumbnail of speech bubbles
Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

#AAIC2022- that's a wrap! Thank you to all who attended our @IMI_EPAD presentations and stopped by the @AlzData booth! For more information, visit our website: ep-ad.org pic.twitter.com/nvctQFS2F4

reply retweet favorite
9:06 pm · 2022-08-04
Twitter
EPAD
EPAD
@IMI_EPAD

It's the final day of #AAIC2022 and your last chance to visit the @AlzData booth 821. Don't miss out an opportunity to pick up some @IMI_EPAD flyers to learn more about our dataset and samples! #openaccess #datasharing #collaboration ep-ad.org/open-access-da… pic.twitter.com/qkRp70t3jN

reply retweet favorite
2:00 pm · 2022-08-04
Twitter
EPAD
EPAD
@IMI_EPAD

Check out the @AlzData #ADWorkbench to access the final @IMI_EPAD dataset including cognitive, biomarker, genomic and neuroimaging data from over 2000 participants of our Longitudinal Cohort Study. #DataSharing #OpenAccess #AAIC2022 ep-ad.org/open-access-da… pic.twitter.com/t5YwfKEqnf

reply retweet favorite
7:06 pm · 2022-08-03
Twitter
EPAD
EPAD
@IMI_EPAD

We have two @IMI_EPAD posters today at #AAIC2022 - come and join @LuigiLorenzini1 and @cumplido_irene to learn more about their work! @fpmaragall @amsterdamumc pic.twitter.com/elEKbDLlhl

reply retweet favorite
2:00 pm · 2022-08-03
Twitter
EPAD
EPAD
@IMI_EPAD

If you're attending #AAIC2022, stop by @LuigiLorenzini1’s poster today, who is talking about alterations of functional connectivity and WM integrity in relationship to early amyloid deposition. @AlzheimerAms pic.twitter.com/Rve4jEJxtT

reply retweet favorite
6:06 pm · 2022-08-02
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT